🔎 Trials Near Me

Domov › Amiloidoza › New York

Klinične študije za Amiloidoza v New York

10 študij za Amiloidoza išče udeležence na lokacijah v New York.

Mesta v New York

Uradno besedilo študije (angleško)

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

  • Icahn School of Medicine at Mt. Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05652335

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

  • Research Site, Manhasset
  • Research Site, New York
  • Research Site, New York
  • in še 1
Vključevanje udeležencevOpazovalna študija
Starost 18–130 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT06465810

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  • Clinical Trial Site, Manhasset
  • Clinical Trial Site, New York
  • Clinical Trial Site, New York
  • in še 2
Vključevanje udeležencevFaza 3
Starost 18–85 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07052903

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  • Clinical Trial Site, New York
  • Clinical Trial Site, New York
Vključevanje udeležencevFaza 3
Starost 18–85 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07223203

ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

  • Clinical Trial Site, New York
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT04561518

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

  • Columbia University Medical Center, New York
Vključevanje udeležencevOpazovalna študija
Starost 30–80 · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT05489549

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • New York University (NYU) School of Medicine - Langone Medical Center, New York
  • Mount Sinai Hospital, New York
  • Columbia University Medical Center, New York
  • in še 1
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT06563895

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

  • Research Site, New York
  • Research Site, New York
  • Research Site, New York
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 2. jul. 2026 · NCT07081646

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

  • Icahn School of Medicine at Mount Sinai /ID# 255408, New York
  • Columbia University Medical Center /ID# 255068, New York
  • Memorial Sloan Kettering Cancer Center-Koch Center /ID# 255073, New York
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 13. maj 2026 · NCT06158854

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  • New York University (NYU) School of Medicine - Langone Medical Center, New York
  • Columbia University Medical Center, New York
Vključevanje udeležencevFaza 3
Starost 18–90 · Vsi spoli · Posodobljeno 27. mar. 2026 · NCT06128629

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.